

Countries included: the Netherlands, working with the WHO collaborating centre Trimbos Georgia Turkey and the USA, working with the American Psychological Association. The NCCMH has also supported several other countries as part of NICE International, establishing guideline development programmes.

A number of guides have also been translated and adopted or adapted by other healthcare systems, including those of Italy, Australia and Slovenia. The NICE clinical guideline on schizophrenia, developed by the NCCMH, was twice recognised by the World Health Organization as being the best developed internationally available guideline on that topic. This work led to further developments in the field of mental health, providing the evidence base that has supported the National Service Framework and the Improving Access to Psychological Therapies (IAPT) programme for depression and anxiety disorders.

It produced the first NICE guideline on schizophrenia, the first guideline on service user experience, and the first guideline in collaboration with the Social Care Institute for Excellence (SCIE) on dementia. The NCCMH began producing clinical guidelines for the National Institute for Health and Care Excellence (NICE).
